Latest News

FDA Expands Approval for Jylamvo Oral Methotrexate Solution in ALL
FDA Expands Approval for Jylamvo Oral Methotrexate Solution in ALL

October 29th 2024

The indication for Jylamvo now includes pediatric patients with acute lymphoblastic leukemia.

FDA Fast Tracks HC-7366 in Relapsed/Refractory Acute Myeloid Leukemia
FDA Fast Tracks HC-7366 in Relapsed/Refractory Acute Myeloid Leukemia

October 28th 2024

Chemotherapy-Free Regimens Gain Ground in Older Patients With ALL
Chemotherapy-Free Regimens Gain Ground in Older Patients With ALL

October 22nd 2024

FDA Grants Rare Pediatric Disease Designation to Galinpepimut-S in AML
FDA Grants Rare Pediatric Disease Designation to Galinpepimut-S in AML

October 17th 2024

FDA Clears IND of Novel ADC in AML Treatment
FDA Clears IND of Novel ADC in AML Treatment

October 14th 2024

More News